Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - GROSS PROFIT
Gross Profit ALNY - Alnylam Pharmaceuticals, Inc.
1.52 B
LAST VALUE
46.82%
2 YEAR CAGR
83.42%
5 YEAR CAGR
41.50%
10 YEAR CAGR